{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:42:11Z","timestamp":1792986131988,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.radonc.2022.02.009","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T03:01:52Z","timestamp":1644980512000},"page":"8-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC \u2013 Hypothesis generation on a multicentre cohort of the DKTK-ROG"],"prefix":"10.1016","volume":"169","author":[{"given":"Steffen","family":"L\u00f6ck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annett","family":"Linge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Lohaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Gudziol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Tinhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goda","family":"Kalinauskaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Guberina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stuschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Balermpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"von der Gr\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca-Ligia","family":"Grosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Ganswindt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Belka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan C.","family":"Peeken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie E.","family":"Combs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"De-Colle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Zips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo B.","family":"Baretton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mechthild","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2022.02.009_b0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2982","article-title":"The molecular biology of head and neck cancer","volume":"11","author":"Leemans","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2022.02.009_b0010","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1200\/JCO.1993.11.11.2136","article-title":"Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot study","volume":"11","author":"Adelstein","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.02.009_b0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","article-title":"An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer","volume":"21","author":"Adelstein","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.02.009_b0020","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1200\/JCO.2004.12.193","article-title":"Concomitant Cisplatin Significantly Improves Locoregional Control in Advanced Head and Neck Cancers Treated With Hyperfractionated Radiotherapy","volume":"22","author":"Huguenin","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.02.009_b0025","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrc2419","article-title":"Exploring the role of cancer stem cells in radioresistance","volume":"8","author":"Baumann","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2022.02.009_b0030","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrc.2016.18","article-title":"Radiation oncology in the era of precision medicine","volume":"16","author":"Baumann","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2022.02.009_b0035","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.radonc.2016.11.008","article-title":"HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation","volume":"121","author":"Linge","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.02.009_b0040","first-page":"40","article-title":"Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy","volume":"16","author":"Linge","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.02.009_b0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.radonc.2017.10.008","article-title":"SDF-1\/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy","volume":"126","author":"De-Colle","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.02.009_b0050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41397-020-0174-1","article-title":"ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy","volume":"21","author":"Guberina","year":"2021","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.radonc.2022.02.009_b0055","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/bjc.2013.640","article-title":"Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer","volume":"110","author":"Balermpas","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2022.02.009_b0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ijc.29683","article-title":"CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG)","volume":"138","author":"Balermpas","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.radonc.2022.02.009_b0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejca.2019.04.015","article-title":"Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group","volume":"116","author":"Eder","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2022.02.009_b0070","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1158\/0008-5472.CAN-11-1182","article-title":"Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer","volume":"71","author":"Toustrup","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2022.02.009_b0075","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3109\/0284186X.2016.1167959","article-title":"Validation of a 15-gene hypoxia classifier in head and neck cancer for prospective use in clinical trials","volume":"55","author":"Toustrup","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2022.02.009_b0080","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1158\/1078-0432.CCR-13-0542","article-title":"A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer","volume":"19","author":"Eustace","year":"2013","journal-title":"Clin Cancer Res An Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.radonc.2022.02.009_b0085","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nrg2665","article-title":"Generating specificity and diversity in the transcriptional response to hypoxia","volume":"10","author":"Lendahl","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.radonc.2022.02.009_b0090","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.radonc.2017.12.007","article-title":"Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC","volume":"127","author":"Linge","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.02.009_b0095","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1109\/JBHI.2015.2450833","article-title":"Toward distributed conduction of large-scale studies in radiation therapy and oncology: open-source system integration approach","volume":"20","author":"Skripcak","year":"2016","journal-title":"IEEE J Biomed Heal Informatics"},{"key":"10.1016\/j.radonc.2022.02.009_b0100","unstructured":"Haase R, Abolmaali, N. A modular Software System for Image Analysis in Positron Emission Tomography. Workshop on Tomography, data processing and image reconstruction for medicine and engineering 2012."},{"key":"10.1016\/j.radonc.2022.02.009_b0105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.radonc.2014.11.011","article-title":"HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group","volume":"113","author":"Lohaus","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.02.009_b0110","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1158\/1078-0432.CCR-15-1990","article-title":"Low cancer stem cell marker expression and low hypoxia identify good prognosis subgroups in HPV(-) HNSCC after postoperative radiochemotherapy: A multicenter study of the DKTK-ROG","volume":"22","author":"Linge","year":"2016","journal-title":"Clin Cancer Res An Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.radonc.2022.02.009_b0115","first-page":"28","article-title":"SDF-1\/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy","volume":"5","author":"De-Colle","year":"2017","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.02.009_b0120","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1158\/1078-0432.CCR-10-0799","article-title":"CD44 expression predicts local recurrence after radiotherapy in larynx cancer","volume":"16","author":"de Jong","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2022.02.009_b0125","first-page":"1271","article-title":"\u201cOxygen effect\u201d and tumor size as related to response of C3H\/Ba adenocarcinoma to local X irradiation","volume":"24","author":"Suit","year":"1960","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2022.02.009_b0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0167-8140(97)00215-6","article-title":"Tumor volume: a basic and specific response predictor in radiotherapy","volume":"47","author":"Dubben","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.02.009_b0135","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1200\/JCO.2008.20.2853","article-title":"Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck","volume":"27","author":"Lassen","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.02.009_b0140","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.radonc.2014.11.032","article-title":"Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer","volume":"113","author":"Lassen","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.02.009_b0145","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.addr.2016.02.002","article-title":"Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments","volume":"109","author":"Krause","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.radonc.2022.02.009_b0150","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1200\/JCO.2015.62.5970","article-title":"Association of human papillomavirus and p16 status with outcomes in the IMCL-9815 Phase III registration trial for patients with locoregionally advanced oropharyngeal squamous cell carcinoma of the head and neck treated with radiotherapy with or without C","volume":"34","author":"Rosenthal","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.02.009_b0155","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1158\/1078-0432.CCR-10-2244","article-title":"CD44: a cancer stem cell-related biomarker with predictive potential for radiotherapy","volume":"16","author":"Baumann","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2022.02.009_b0160","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1200\/JCO.2010.29.2904","article-title":"Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial","volume":"28","author":"Rischin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.02.009_b0165","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejca.2013.11.010","article-title":"Cancer stem cell enrichment marker CD98: A prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer","volume":"50","author":"Rietbergen","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2022.02.009_b0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cbi.2016.12.015","article-title":"ERCC2\/XPD Lys751Gln alter DNA repair efficiency of platinum-induced DNA damage through P53 pathway","volume":"263","author":"Zhang","year":"2017","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.radonc.2022.02.009_b0175","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/hed.23217","article-title":"Focus on the role of the CXCL12\/CXCR4 chemokine axis in head and neck squamous cell carcinoma","volume":"35","author":"Albert","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2022.02.009_b0180","doi-asserted-by":"crossref","first-page":"14259","DOI":"10.18632\/oncotarget.7423","article-title":"BK K+ channel blockade inhibits radiation-induced migration\/brain infiltration of glioblastoma cells","volume":"7","author":"Edalat","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2022.02.009_b0185","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1158\/1078-0432.CCR-10-2636","article-title":"CXCL12 (SDF1alpha)-CXCR4\/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies?","volume":"17","author":"Duda","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2022.02.009_b0190","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.ijrobp.2021.03.031","article-title":"The oral CXCR4 inhibitor X4\u2013136 improves tumor control and reduces toxicity in cervical cancer treated with radiation therapy and concurrent chemotherapy","volume":"110","author":"Chaudary","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.02.009_b0195","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1158\/1078-0432.CCR-18-2951","article-title":"The CD98 heavy chain is a marker and regulator of head and neck squamous cell carcinoma radiosensitivity","volume":"25","author":"Digomann","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2022.02.009_b0200","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jclinepi.2006.01.014","article-title":"Review: A gentle introduction to imputation of missing values","volume":"59","author":"Donders","year":"2006","journal-title":"J Clin Epidemiol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022000949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022000949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:19:26Z","timestamp":1759123166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814022000949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":40,"alternative-id":["S0167814022000949"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2022.02.009","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC \u2013 Hypothesis generation on a multicentre cohort of the DKTK-ROG","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2022.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}